CUE
Cue Biopharma
27.70$
+23.9%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 427.3% | 740.6% | 49.4% | 358.5% | – | – | – | 3.4% | 3.7% | 14.6% | 1.4% | 0.5% | 9.0% | |
| -327.3% | -640.6% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 96.3% | 100.0% | 100.0% | 99.5% | 99.7% | |
| 470.2% | 597.9% | 594.0% | 358.5% | 281.2% | 455.8% | 2,030.2% | 267.8% | 218.1% | 75.3% | 121.3% | 622.2% | 204.8% | |
| 173.6% | 253.1% | 243.8% | 131.9% | 85.9% | 255.1% | 991.2% | 124.4% | 229.3% | 15.7% | 73.0% | 591.2% | 156.9% | |
| 216.4% | 118.9% | 837.8% | 490.6% | 364.2% | 711.2% | 3,021.4% | 392.3% | 447.4% | 91.1% | 194.3% | 1,213.3% | 361.8% | |
| -543.8% | -759.6% | -737.8% | -390.6% | -264.2% | -611.2% | -2,921.4% | -292.3% | -351.0% | 8.9% | -94.3% | -1,113.3% | -262.0% | |
| 13.6% | 27.8% | 14.0% | 8.1% | 5.6% | 9.7% | 30.4% | 1.5% | 3.5% | 0.2% | 0.1% | 0.1% | 0.4% | |
| -524.0% | -737.7% | -719.1% | -382.7% | -259.6% | -602.5% | -2,911.4% | -287.1% | -346.6% | 9.5% | -91.1% | -1,943.2% | -434.5% | |
| 33.3% | 44.3% | 46.9% | – | -259.6% | – | – | – | – | 2.3% | – | – | – | |
| -524.0% | -737.7% | -719.1% | -382.7% | -259.6% | -602.5% | -2,911.4% | -287.1% | -346.6% | 7.2% | -91.1% | -1,943.2% | -435.8% | |
| -504.2% | -744.8% | -655.6% | -342.0% | -227.7% | -586.6% | -2,671.5% | -258.7% | -339.4% | 15.2% | -74.7% | -1,113.3% | -254.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.